Antiphospholipid Antibody Syndrome with Fahr's Syndrome Secondary to Systemic Lupus Erythematosus：a Case Report and Literature Review

doi:10.12114/j.issn.1007-9572.2019.00.095

Abstract

Abstract: In systemic lupus erythematosus （SLE） patients，about 20% have secondary antiphospholipid antibody syndrome（AAS），but it is rare for them with secondary Fahr's syndrome at the same time.We reported a case of AAS with Fahr's syndrome secondary to SLE，and reviewed the related literature.Moreover，we discussed the pathogenesis and treatment of extensive intracranial calcifications，and the role of antiphospholipid antibody in the development of Fahr's syndrome secondary to SLE.It is suggested that it is necessary for clinicians to diagnose AAS secondary to SLE at an early stage，and to give personalized anticoagulant therapy timely.

Key words: Lupus erythematosus, systemic；Antiphospholipid syndrome；Fahr's disease；Case reports

摘要： 在系统性红斑狼疮中，约20%的患者可继发抗磷脂抗体综合征，但同时合并Fahr综合征的患者临床上甚是罕见。本文报道1例系统性红斑狼疮继发抗磷脂抗体综合征且合并Fahr综合征的患者，并对相关文献进行回顾，探讨颅内广泛脑组织钙化的发病机制及治疗方法，从而发现抗磷脂抗体在系统性红斑狼疮并发Fahr综合征方面所发挥的作用，提示临床医生早期诊断继发性抗磷脂抗体综合征并给予个体化抗凝治疗非常必要。

关键词: 红斑狼疮, 系统性；抗磷脂抗体综合征；华尔思综合征；病例报告

DU Yumei,QIN Ting,GAO Wei, et al. Antiphospholipid Antibody Syndrome with Fahr's Syndrome Secondary to Systemic Lupus Erythematosus：a Case Report and Literature Review　[J]. Chinese General Practice, 2019, 22(35): 4406-4408. DOI: 10.12114/j.issn.1007-9572.2019.00.095.
杜玉梅,覃婷,高薇等. 系统性红斑狼疮继发抗磷脂抗体综合征合并Fahr综合征一例报道并文献复习[J]. 中国全科医学, 2019, 22(35): 4406-4408. DOI: 10.12114/j.issn.1007-9572.2019.00.095.

References

［1］秦毅，顾志峰，李立人，等．女性系统性红斑狼疮患者性功能障碍状况及影响因素研究［J］．中国全科医学，2016，19（34）：4187-4195．DOI：10.3969/j.issn.1007-9572.2016.34.008.
QIN Y，GU Z F，LI L R，et al．Sexual dysfunction status and influencing factors of female patients with systemic lupus erythematosus［J］．Chinese General Practice，2016，19（34）：4187-4195．DOI：10.3969/j.issn.1007-9572.2016.34.008.
［2］FAHR T.Idiopathische verkalkung der Hirngef?sse［J］．Zentralbl Allg Pathol，1930，50：129-133.
［3］MANYAM B V.What is and what is not ‘Fahr's disease’［J］．Parkinsonism Relat Disord，2005，11（2）：73-80．
［4］CA?AS C A，TOBóN G J.Multiple brain calcifications in a patient with systemic lupus erythematosus［J］．Clin Rheumatol，2008，27（Suppl 2）：S63-65．DOI：10.1007/s10067-008-0933-x.
［5］MASUDA Y，UCHIYAMA Y，HASHIMOTO S，et al．Symmetrical progressive intracranial calcification in a patient with SLE［J］．Intern Med，2010，49（4）：351．
［6］RAYMOND A A，ZARIAH A A，SAMAD S A，et al．Brain calcification in patients with cerebral lupus［J］．Lupus，1996，5（2）：123-128．DOI：10.1177/096120339600500207.
［7］FILLOUX V，MAROTTE H，MIOSSEC P.Cerebral calcifications in an elderly lupus patient［J］．Ann Rheum Dis，2003，62（3）：283-284．DOI：10.1136/ard.62.3.283.
［8］STUART B M，GREGSON N A.Cerebral calcification in a patient with systemic lupus erythematosus and a monoclonal IgG reactive with glial fibrillary acidic protein［J］．Br J Rheumatol，1998，37（12）：1355-1357.
［9］MARTINOVIC-KALITERNA D，RADIC M，RADIC J，et al．Massive cerebral calcifications （Fahr's disease） in a patient with systemic lupus erythematosus and no major neuropsychological abnormality［J］．Isr Med Assoc J，2013，15（10）：654-655.
［10］HORINO T，MATSUMOTO T，INOUE K，et al．Bilateral striopallidodentate calcinosis associated with Sj?gren's syndrome and IgDλ monoclonal gammopathy of undetermined significance［J］．Joint Bone Spine，2018，85（2）：243-245．
［11］CHANG R S，LEUNG C Y，LEONG H S.Bilateral striatopallidodentate calcinosis associated with systemic lupus erythematosus：case report and review of literature［J］．J Neurol Sci，2015，358（1/2）：518-519．
［12］WILSON W A，GHARAVI A E，KOIKE T，et al．International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome：Report of an International workshop［J］．Arthritis Rheum，1999，42（7）：1309-1311．
［13］KUMAR M，TYAGI N，MOSHAL K S，et al．Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery［J］．Neurochem Int，2008，53（6/7/8）：214-219．
［14］ANDRES R H，SCHROTH G，REMONDA L.Extensive cerebral calcification in a patient with systemic lupus erythematosus［J］．BMJ Case Rep，2008，79（4）：365．
［15］张华峰，马信龙.激素性股骨头坏死的骨质疏松学说［J］．中国骨质疏松杂志，2007，13（2）：130-133．http://www.cnki.com.cn/Article/CJFDTotal-ZGZS200702015.htm.
［16］张秋霞，陈镇秋.系统性红斑狼疮并发股骨头缺血性坏死的相关性临床研究［J］．新中医，2008，40（8）：27-28．

[1]	Fanni XIAO, Yufeng QING, Quanbo ZHANG. Latest Advances in the Role of JAK/STAT Signaling Pathway in Autoimmune Rheumatic Diseases [J]. Chinese General Practice, 2022, 25(17): 2159-2164.
[2]	CUI Peng，XU Dong，XING Tian，REN Guohua，MA Shangmin. Clinical Analysis of Systemic Lupus Erythematosus with Persistent Thrombocytosis　 [J]. Chinese General Practice, 2021, 24(14): 1827-1830.
[3]	MA Wenjing，Soon-Min Hong，CAO Lanfang. Systemic Lupus Erythematosus Combined with Sensorineural Hearing Loss in Children：a Case Study and Literature Review　 [J]. Chinese General Practice, 2020, 23(29): 3763-3766.
[4]	XING Yixi，CHEN Weifei，XU Xiayu，LIN Qianqi，YAO Qicen，LI Jianhong. Serum Vascular Endothelial Growth Factor Levels in Systemic Lupus Erythematosus Patients with or without Antiphospholipid Syndrome：a Comparative Study　 [J]. Chinese General Practice, 2019, 22(24): 2918-2923.
[5]	ZHANG Zongwei，CHEN Cheng，WANG Huiming，DING Guohua. Correlation of Serum β2-microglobulin Level with Disease Activity of Systemic Lupus Erythematosus and Degree of Lupus Nephritis　 [J]. Chinese General Practice, 2019, 22(17): 2058-2063.